Phase
Condition
Cancer
Digestive System Neoplasms
Pancreatitis
Treatment
Food Diary
Activity tracker
Continuous glucose monitors
Clinical Study ID
Ages 18-85 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Pancreatic cancer patients
Inclusion Criteria:
Aged 18-85
Sex: male/female
Radiological/tissue cancer diagnosis
World Health Organisation performance status of 2 or below
Patients with jaundice must have jaundice relieved before participating
Exclusion
Exclusion Criteria:
Pregnancy
Planned surgery within the 7 days of wearing the monitor
Emergency surgery
Part of any other trial with similar interventions
Any musculoskeletal, cardiovascular, or neurological disorder that could put them atrisk during the protocol.
World Health Organisation performance status of above 2.
Have diabetes at the point of diagnosis.
Healthy control group
Inclusion:
Aged 18-85
No serious underlying health conditions
Age matched to pancreatic cancer patients
Exclusion:
Take any medications which may alter blood glucose concentrations orinsulin/glucagon concentrations, regular paracetamol intake during the study period,corticosteroids, thyroid hormones, or any anti-diabetes medication including insulinand oral hypoglycaemics.
Pregnant
Study Design
Study Description
Connect with a study center
Lancaster University
Lancaster, Lancashire LA1 4YW
United KingdomSite Not Available
East Lancashire Hospitals Trust
Blackburn, BB2 3HH
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.